UP!

News

Asterias Biotherapeutics, Inc. (healthcare)

Q reports

Period Date Adjusted Actuals EPS GAAP EPS

Ratings

8696-03-09
6077-02-14
5869-03-07
5861-03-21
3232-02-26
3025-03-19
2016-05-26 Reiterated Rating FBR & Co. Buy
2016-05-26 Reiterated Rating FBR & Co Buy
2016-05-23 Initiated Coverage Chardan Capital Buy $5.50
2016-05-17 Reiterated Rating Rodman & Renshaw Buy $10.00
2016-04-25 Initiated Coverage Rodman & Renshaw Buy $12.00
2016-01-25 Reiterated Rating FBR & Co. Outperform
2015-11-19 Initiated Coverage FBR & Co. Outperform $10.00
2015-08-11 Reiterated Rating MLV & Co. Buy $9.00
2015-05-05 Initiated Coverage Lake Street Capital Buy $22.00
2015-03-09 Reiterated Rating MLV & Co. Buy $9.00
2015-02-27 Initiated Coverage MLV & Co. Buy $9.00
1970-01-01
0178-03-31
8696-03-09
6077-02-14
5869-03-07
5861-03-21
3232-02-26

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Funds

In AST 0 funds of 2184 total. Show all

Fund name Ticker shares

Major Shareholders

Name Relationship Total Shares Holding stocks

Comments